Vitamin B12 supplement / Cobalamin

This page covers all Vitamin B12 supplement / Cobalamin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Methionine synthase; methylmalonyl-CoA mutase cofactor, Methionine synthase, COX-2 enzyme; cyanocobalamin (B12 cofactor).

Targets

Methionine synthase; methylmalonyl-CoA mutase cofactor · Methionine synthase · COX-2 enzyme; cyanocobalamin (B12 cofactor)

Marketed (2)

• Methylcobalamin (methylB12) · Arkansas Children's Hospital Research Institute · Neurology; Hematology; Nutritional deficiency
  Methylcobalamin is an active form of vitamin B12 that serves as a cofactor for methionine synthase and other enzymes involved in DNA synthesis, myelin formation, and neurological function.
• Methyl B12 · University of California, San Francisco · Hematology / Neurology
  Methylcobalamin (Methyl B12) acts as a coenzyme in one-carbon transfer reactions and methionine synthesis, supporting DNA synthesis, myelin formation, and neurological function.

Phase 3 pipeline (1)

• Etoricoxib + Cyanocobalamin fixed dose · Laboratorios Silanes S.A. de C.V. · Pain management / Rheumatology
  Etoricoxib selectively inhibits COX-2 to reduce inflammation and pain, while cyanocobalamin (vitamin B12) supports neurological function and red blood cell formation.

Patent intelligence

• vitamin b12 supplement patent landscape — aggregated cliff calendar, attackable patents, originator estates